Project Grant T32TR005991
Award Date 8/1/26
Completion Date 5/31/31
Dollars Obligated $559K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15222, USA
Similar Awards
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $502,465 on August 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral T32 training initiative in clinical and translational research. The award funds the University of Pittsburgh Institute for Clinical Research Education (ICRE) to deliver comprehensive postdoctoral fellowship training and career development programs designed to equip...
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $1,025,770 on August 1, 2026, under the NCATS K12 Program (CFDA 93.350) to develop the next generation of clinical and translational research experts and translational scientists. The University of Pittsburgh will train scholars in translational science and domain-specific skills required for careers as clinical and translational researchers and translational scientists, provide cross-disciplinary...
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded the University of Pittsburgh a cooperative agreement totaling $10,192,245 on July 15, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350). The University of Pittsburgh Clinical and Translational Science Institute will operate as a learning research system to systematically identify and disseminate generalizable methods that accelerate translational research...
- The National Institutes of Health National Center for Advancing Translational Sciences awarded the University of Pennsylvania $532,701 on July 6, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral training program in clinical and translational science. The award funds the CTSA Postdoctoral T32 at Penn, which trains clinical and translational science investigators to move scientific discoveries from the laboratory into clinical...
- The National Center for Advancing Translational Sciences awarded the University of Massachusetts Medical School $328,040 on August 15, 2026, under the CTSA Predoctoral T32 training program (Assistance Listing 93.350) to develop a two-year predoctoral training program in clinical and translational science. The program will recruit three cohorts of six doctoral students with guaranteed funding across rigorous doctoral programs in nursing, MD/PhD, population health sciences, epidemiology,...
- The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $1.62 million on August 1, 2026, under the NCATS program (CFDA 93.350) to operate a mentored research career development program in clinical and translational science. The University of Pennsylvania will identify, recruit, train, and retain nine early-career scientists across varied educational backgrounds and professional experiences, guiding them toward scientific independence and leadership in...
- The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $553,631 on July 6, 2026, under the CTSA Predoctoral T32 program (CFDA 93.350) to support predoctoral trainee development in clinical and translational science. The award funds a predoctoral training program that will support 10 trainees at any given time, recruited from PhD, MD, DMD, and VMD doctoral programs, with individual appointments lasting 1–3 years depending on career stage. The training plan...
- The National Center for Advancing Translational Sciences awarded Johns Hopkins University $1,644,144 on September 15, 2025, under the CTSA Postdoctoral T32 program (CFDA 93.350) to operate an integrated postdoctoral training program in clinical and translational research through August 31, 2030. The program delivers mentored training in translational science core principles, biodesign methodology and research applications, and community engagement skills to postdoctoral trainees. The...
- The National Center for Advancing Translational Sciences awarded a cooperative agreement totaling $7.892 million to Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) on August 6, 2026, under CFDA 93.350. The award funds the Penn State Clinical and Translational Science Institute (CTSI) to advance clinical and translational science through investigator-centered research infrastructure, development and dissemination of innovations, expansion of Pennsylvania's...
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded a cooperative agreement to New York University on March 20, 2026, obligating $38.325 million under CFDA 93.350 (National Center for Advancing Translational Sciences). The award funds the New York University Clinical and Translational Science Institute (CTSI) hub, which will enhance community-engaged research, democratize health informatics resources, develop a well-rounded translational...